Clostridium difficile infection in patients with reactive arthritis of undetermined etiology

Scandinavian Journal of Rheumatology

Volumn 27, Issue 5, 1998, Pages 357-362

  Kocar I H ^a   Caliskaner Z ^a,b   Pay, S ^a   Turan, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Basinevler ^*  (Turkey)

Author keywords

Clostridium difficile; Reactive arthritis

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL TOXIN; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COLESTYRAMINE; FLUCLOXACILLIN; FLURBIPROFEN; GENTAMICIN; IBUPROFEN; INDOMETACIN; LINCOMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PENICILLIN V; PHENYLBUTAZONE; SALAZOSULFAPYRIDINE; STEROID; SULBACTAM; TINIDAZOLE; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ARTHRITIS, REACTIVE; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; DRUG RESISTANCE, MICROBIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; MALE; PROGNOSIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 0031785090     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749850154384     Document Type: Article

References (25)

1. Svenungsson B. Reactive arthritis. BMJ 1994;308:671-72.
2. Toivanen A, Granfors K. New views into the pathogenesis of reactive arthritis [editorial]. Ann Med 1990;22:3-4.
3. Pothoulakis C, LaMont JT. Clostridium difficile colitis and diarrhea. Gastroenterol Clin North Am 1993;22:623-37.
4. Mc Farland LV, Mulligan ME, Kwokk RYY, Stam WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
5. Kelly CP, Pothohoulakis C. C. Difficile colitis. N Engl J Med 1994;27:257-62.
6. Thomas D, Bennet RG, Laughan BE, Greenought WG. Post-antibiotic colonization with Clostridium difficile in nursing home patients. J Am Geriatr Soc 1990;38:415-20.
7. Atkinson MH, McLeod BD. Reactive arthritis associated with Clostridium difficile enteritis. J Rheumatol 1988;15:520-22.
8. Boice JL. Reactive arthritis induced by C. difficile. West J Med 1994;160:171-2.
9. Cope A, Anderson J, Wilkins EC. difficile toxin induced reactive arthritis in a patient with chronic Reiter syndrome. Eur J Clin Microbiol Infect Dis 1992;11:40-3.
10. Hannonen P, Hakola M, Möttönen T, Oka M. Reactive oligoarthritis associated with Clostridium difficile colitis. Scand J Rheumatol 1989;18:57-60.
11. Hayward RS, Wensel RH, Kibsey P. Relapsing Clostridium difficile colitis and Reiter's syndrome. Am J Gastroenterol 1990;85:752-56.
12. Keating RM, Vyas AS. Reactive arthritis following Clostridium difficile colitis. West J Med 1995;162:61-3.
13. Lofgren RP, Tadlock LM, Soltis RD. Acute oligoarthritis associated with Clostridium difficile pseudomembranous colitis. Arch Intern Med 1984;144:617-19.
14. Mermel LA, Osborn TG. Clostridium difficile associated reactive arthritis in an HLA-B27 positive female: report and literature review. J Rheumatol 1989;16:133-35.
15. Putterman C, Rubinow A. Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum 1993;22:420-26.
16. Sensini A, Marroni M, Bassoti G, Farinelli S, D'Alo F, Gentili AM, et al. Clostridium difficile-associated reactive arthritis in HLA B-27 negative male. J Clin Gastroenterol 1988;16:354-55.
17. Cush JJ, Lipsky PE. Reiter's syndrome and reactive arthritis. In: McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions. Thirteen Edition. Philadelphia, London: Lea & Febiger, Philadelphia, London, 1997:1209-27.
18. Toivanen A. Reactive arthritis In: Klippel JH, Dieppe PA., eds. Rheumatology,. Mosby, London,: Mosby, 1994;4.9:1-8.
19. Mitty RD, LaMont T. Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment. Gastroenterol 1994; 2:61-9.
20. Fekety R, Shah A. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993;269:71-5.
21. Lyerly DM, Krivan HC, Wilkins TD. Clostridium difficile: Its disease and toxins. Clin Microbiol Rev 1988;1:1-18.
22. Foley ND, Coughlan RJ, Sugrue D. Toxic shock syndrome associated arthropathy. Staphylococcus aureus: a further triggering event in reactive arthritis? Ann Rheum Dis 1989;48:331-32.
23. Choi VM, Coates JE, Chooi J, Thomson AB, Russell AS. Small bowel permeability: a variable effect of NSAIDs. Clin Invest Med 1995;18:357-61.
24. Battarbee HD, Grisham MB, Johnson GG, Zavecz JH. Superior mesenteric artery blood flow and indomethacin-induced intestinal injury and inflammation. Am J Physiol. 1996; 271:605-12.
25. Shanholtzer CJ, Willard KE, Holter JJ, Olson MM, Gerding DN. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with Clostridium difficile culture and cytotoxin and latex tests. J Clin Microbiol 1992;30:1837-40.